Page last updated: 2024-08-22

tiletamine hydrochloride and Osteoporosis

tiletamine hydrochloride has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bentkowski, Z; Holme, E; Lindstedt, S; Pronicka, E; Rowinska, E; Zawadzki, J	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Osteoporosis

Article	Year
Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC). Journal of inherited metabolic disease, 1996, Volume: 19, Issue:2 Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Child; Cyclohexanones; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Male; Nitrobenzoates; Osteoporosis; Phosphates; Reference Values; Tyrosine; Uric Acid	1996

Article

Year

Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase inhibitor (NTBC).

Journal of inherited metabolic disease, 1996, Volume: 19, Issue:2

Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Amino Acid Metabolism, Inborn Errors; Child; Cyclohexanones; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Male; Nitrobenzoates; Osteoporosis; Phosphates; Reference Values; Tyrosine; Uric Acid

1996